Skip to main content
logo
Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
15.98
+0.11 (0.69%)
Feb 20, 2026, 2:49 PM EST - Market open

Summit Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
---0.711.810.86
Revenue
---0.711.810.86
Revenue Growth (YoY)
----61.03%110.35%6.10%
Gross Profit
---0.711.810.86
Selling, General & Admin
493.6660.5330.2726.7423.6119.23
Research & Development
441.76150.7859.475285.3553.27
Other Operating Expenses
-0.31-0.31-1-14.42-20.97-19.31
Operating Expenses
935.11210.9988.7464.338853.19
Operating Income
-935.11-210.99-88.74-63.62-86.19-52.33
Interest Expense
-0.01-8.69-16.46-4.4-0.24-0.26
Interest & Investment Income
14.3413.4710.41.51-0
Currency Exchange Gain (Loss)
-0.79-0.11.03-4.11-2.140.05
Other Non Operating Income (Expenses)
-0.05--0.250.3-0.040.48
EBT Excluding Unusual Items
-921.62-206.31-94.01-70.31-88.6-52.05
Asset Writedown
----8.47--0.86
Pretax Income
-921.62-221.32-614.93-78.78-88.6-52.91
Income Tax Expense
------0.21
Net Income
-921.62-221.32-614.93-78.78-88.6-52.7
Net Income to Common
-921.62-221.32-614.93-78.78-88.6-52.7
Shares Outstanding (Basic)
7407196201939270
Shares Outstanding (Diluted)
7407196201939270
Shares Change (YoY)
4.36%15.96%220.50%109.60%32.67%111.78%
EPS (Basic)
-1.24-0.31-0.99-0.41-0.96-0.76
EPS (Diluted)
-1.25-0.31-0.99-0.41-0.96-0.76
Free Cash Flow
-270.17-142.25-76.89-42.21-72.89-48.53
Free Cash Flow Per Share
-0.36-0.20-0.12-0.22-0.79-0.70
Gross Margin
---100.00%100.00%100.00%
Operating Margin
----9024.25%-4764.29%-6085.35%
Profit Margin
----11174.75%-4897.84%-6127.56%
Free Cash Flow Margin
----5986.67%-4029.46%-5643.26%
EBITDA
-934.99-210.9-88.54-62.36-84.84-50.78
D&A For EBITDA
0.130.090.21.261.351.55
EBIT
-935.11-210.99-88.74-63.62-86.19-52.33
Updated Oct 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q